Job Search and Career Advice Platform

Aktiviere Job-Benachrichtigungen per E-Mail!

Sr. Manager, Drug Substance MSAT

Apellis Pharmaceuticals

Zug

Hybrid

CHF 100’000 - 140’000

Vollzeit

Vor 3 Tagen
Sei unter den ersten Bewerbenden

Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf

Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren

Zusammenfassung

A global biopharmaceutical company is seeking a Senior Manager of Drug Substance MSAT in Zug, Switzerland. The role involves leading tech transfer, process optimization, and validation at manufacturing sites, requiring extensive cGMP experience and a strong MSAT background. The successful candidate will collaborate with cross-functional teams and have expertise in process development and lifecycle management. This position offers the chance to contribute to innovative therapies in a dynamic environment, with flexible working arrangements.

Leistungen

Comprehensive benefits package
Flexible time off
Paid family leave

Qualifikationen

  • Extensive experience in cGMP development and manufacturing.
  • Deep knowledge of pharmaceutical processes and technologies.
  • Proven track record in MSAT or related fields.

Aufgaben

  • Lead tech transfer, process qualification, and validation.
  • Oversee product launch and change management.
  • Support risk management and troubleshooting.
  • Ensure qualification of processes, facilities, and equipment.

Kenntnisse

Attention to detail
Project management
Technical skills
Communication skills
Problem-solving
Organizational skills
Teamwork

Ausbildung

Bachelor’s degree in life sciences/engineering
Advanced degree (MS/PhD) preferred
Jobbeschreibung
Senior Manager, Drug Substance MSAT

Apellis Pharmaceuticals

Location: Zug, Switzerland (requires 2‑3 days office presence per week)

Employment type: Full‑time, Mid‑Senior level

Job Function: Other

Summary

As part of the MSAT team, the Senior Manager of Drug Substance (DS) Manufacturing Science and Technology (MSAT) will lead tech transfer, process qualification, and validation at contract drug substance manufacturing sites. Responsibilities include process scalability, PPQ, monitoring, optimization, and manufacturability of drug substance and key intermediates. The role requires broad expertise in manufacturing and late‑stage/commercial operations, supporting cross‑functional teams. Technical support will be provided for both late‑stage lifecycle and early‑stage pipeline projects.

Roles And Responsibilities
  • Serve as MSAT technical expert on internal/external projects (process implementation, validation, tech transfer).
  • Oversee product launch, tech transfer, process characterization (e.g., DOE, fate/purge studies), validation, and change management.
  • Support risk management and troubleshooting for major deviations/change controls in collaboration with the supplier relationship team (SRT).
  • Manage development and manufacturing activities through transparent communication and strategic alignment.
  • Lead technical transfer and lifecycle planning from a manufacturing/scientific perspective.
  • Proactively resolve technical challenges, deviations, and issues within scope.
  • Ensure qualification/validation of processes, facilities, equipment, raw materials, and cleaning methods per GMP and global health regulations.
  • Collaborate with cross‑functional teams (PM, QC, QA, Supply Chain, Regulatory) for tech transfer, scale‑up, and PPQ.
  • Build strong relationships with development and manufacturing partners; coordinate with internal teams.
  • Confirm equipment qualification as part of process validation (installation, operation, performance).
  • Identify opportunities for continuous process improvement via trend analysis, technology advances, and industry standards.
  • Support evaluation of major deviations, root cause analysis, CAPA, and change control with focus on quality, risk mitigation, and compliance.
  • Apply risk management tools (e.g., FMEA, gap analysis) throughout lifecycle management.
  • Develop data management processes for operational analysis, including Annual Product Review (APR) and Continuous Process Verification (CPV).
  • Contribute to writing and reviewing CTD Module 3 sections for regulatory submissions (NDA, PAS, etc.).
Required Qualifications
  • Bachelor’s degree in life sciences/engineering; advanced degree (MS/PhD) preferred.
Experience
  • Extensive experience in cGMP development and manufacturing with strong MSAT background.
  • Deep knowledge of pharmaceutical processes, technologies, and systems; experience in process development, tech transfer, scale‑up, validation, and manufacturing.
  • Proven track record in MSAT or related fields.
  • Experience in process validation and lifecycle management.
  • Familiarity with CTD Module 3 authorship and regulatory standards (FDA, EMA, ICH).
  • Expertise in at least two modalities (e.g., peptides, oligonucleotides, biologics, small molecules, gene therapy) is a plus.
Skills, Knowledge & Abilities
  • Strong attention to detail and hands‑on approach to project management (data, reports, dashboards, budgets).
  • Excellent technical, communication, problem‑solving, and organizational skills.
  • Effective team player with ability to build strong internal/external relationships.
Other Requirements
  • Valid passport and ability to travel.
  • Position based in Zug, Switzerland and requires 2‑3 days office presence per week.
  • Eligibility to work in Switzerland.
Travel Requirements

Valid passport and ability to travel.

Education

Bachelor's Degree

Benefits And Perks

Apellis offers a comprehensive benefits package, inclusive flexible time off, summer and winter shutdowns, paid family leave and more!

Company Background

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life‑changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3‑targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first‑ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC‑MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

Other Duties

Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.

Hol dir deinen kostenlosen, vertraulichen Lebenslauf-Check.
eine PDF-, DOC-, DOCX-, ODT- oder PAGES-Datei bis zu 5 MB per Drag & Drop ablegen.